BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31416410)

  • 1. Perspectives in Allergen-Specific Immunotherapy: Molecular Evolution of Peptide- and Protein-Based Strategies.
    Jacquet A
    Curr Protein Pept Sci; 2020; 21(2):203-223. PubMed ID: 31416410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation?
    Pechsrichuang P; Jacquet A
    Clin Exp Allergy; 2020 May; 50(5):543-557. PubMed ID: 32078207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
    Valenta R; Campana R; Focke-Tejkl M; Niederberger V
    J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
    Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of Food Allergy: a Comprehensive Review.
    Wai CYY; Leung NYH; Leung PSC; Chu KH
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):55-73. PubMed ID: 28929421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant allergens for immunotherapy: state of the art.
    Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with peptides.
    Moldaver D; Larché M
    Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation immunotherapy for tree pollen allergies.
    Su Y; Romeu-Bonilla E; Heiland T
    Hum Vaccin Immunother; 2017 Oct; 13(10):2402-2415. PubMed ID: 28853984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy and asthma: efficacy, safety, and other considerations.
    Cox L
    Allergy Asthma Proc; 2008; 29(6):580-9. PubMed ID: 19173785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Macchia L; Di Lorenzo G
    Allergy; 2017 May; 72(5):691-704. PubMed ID: 27926981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.
    Curin M; Khaitov M; Karaulov A; Namazova-Baranova L; Campana R; Garib V; Valenta R
    Curr Allergy Asthma Rep; 2018 Jun; 18(7):39. PubMed ID: 29886521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.